ESOMEPRAZOLE MAGNESIUM - esomeprazole magnesium capsule, delayed release 
Rising Pharma Holdings, Inc.

----------

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg
Drug Facts

Active ingredient (in each capsule)
Purpose
Esomeprazole 20 mg
Acid reducer
(Each delayed-release capsule corresponds to 22.250 mg esomeprazole magnesium trihydrate)

Uses

Warnings

Allergy alert

Do not use if you are allergic to esomeprazole

Do not use if you have

These may be signs of a serious condition. See your doctor.

Ask a doctor before use if you have

Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.

Stop use and ask a doctor if

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

14-Day Course of Treatment

Repeated 14-Day Courses (if needed)

Other Information

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg:

FD&C Blue 2, Gelatin, Hydroxypropyl Cellulose, Hypromellose, Magnesium Stearate, Methacrylic Acid and Ethyl Acrylate Copolymer Dispersion, Mono-and Di-Glycerides, Pharmaceutical Ink, Polysorbate 80, Sugar Spheres, Talc, Triethyl Citrate.

Questions or comments?

Call toll-free weekdays 9 AM to 5 PM EST at 1-844-474-7464.

Contact Graviti Pharmaceuticals Inc., or www.gravitipharma.com; or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Made in India

See new warning information

Esomeprazole magnesium delayed-release capsules 20 mg/acid reducer

May take 1 to 4 days for full effect

14 CAPSULES

One 14-day course of treatment Capsules

Tips for Managing Heartburn

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel - 20 mg Capsules: Container Label

NDC 16571-880-41

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg

24 HR

Acid Reducer

Treats Frequent Heartburn

May take 1 to 4 Days for Full effect

14 Capsules

One 14-day Course of Treatment

Distributed by: Rising Pharma Holdings, Inc.

image

Principal Display Panel - 20 mg Capsules: Carton Label

NDC 16571-880-41

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg

24 HR

Acid Reducer

Treats Frequent Heartburn

May take 1 to 4 Days for Full effect

14 Capsules

One 14-day Course of Treatment

Distributed by: Rising Pharma Holdings, Inc.

image

Principal Display Panel - 20 mg Capsules: Carton Label

NDC 16571-880-42

Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg

24 HR

Acid Reducer

Treats Frequent Heartburn

May take 1 to 4 Days for Full effect

42 Capsules

Three 14-day Courses of Treatment

Distributed by: Rising Pharma Holdings, Inc.

image
ESOMEPRAZOLE MAGNESIUM 
esomeprazole magnesium capsule, delayed release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:16571-880
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ESOMEPRAZOLE MAGNESIUM (UNII: R6DXU4WAY9) (ESOMEPRAZOLE - UNII:N3PA6559FT) ESOMEPRAZOLE20 mg
Inactive Ingredients
Ingredient NameStrength
RAW SUGAR (UNII: 8M707QY5GH)  
HYPROMELLOSE 2910 (5 MPA.S) (UNII: R75537T0T4)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
HYDROXYPROPYL CELLULOSE, UNSPECIFIED (UNII: 9XZ8H6N6OH)  
TALC (UNII: 7SEV7J4R1U)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER (1:1) TYPE A (UNII: NX76LV5T8J)  
TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
GELATIN, UNSPECIFIED (UNII: 2G86QN327L)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
GLYCERYL DISTEARATE (UNII: 73071MW2KM)  
Product Characteristics
ColorWHITE (white opaque colored) Scoreno score
ShapeCAPSULESize14mm
FlavorImprint Code 20mg;223
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:16571-880-411 in 1 CARTON12/01/2022
114 in 1 BOTTLE; Type 0: Not a Combination Product
2NDC:16571-880-423 in 1 CARTON12/01/2022
214 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA21634912/01/2022
Labeler - Rising Pharma Holdings, Inc. (116880195)
Establishment
NameAddressID/FEIBusiness Operations
Graviti Pharmaceuticals Private Limited650884781MANUFACTURE(16571-880) , ANALYSIS(16571-880)

Revised: 5/2023
Document Id: cd6b21e6-4d3f-40b5-89ee-52a1c83d8700
Set id: 07ba5747-702f-47fc-9d80-5a70296b64bf
Version: 3
Effective Time: 20230511
 
Rising Pharma Holdings, Inc.